<bill session="116" type="h" number="4812" updated="2023-01-11T13:44:19Z">
  <state datetime="2020-11-17T13:43:08-05:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2020-11-17T13:43:08-05:00"/>
  </status>
  <introduced datetime="2019-10-23"/>
  <titles>
    <title type="display">Ensuring Compliance Against Drug Diversion Act of 2020</title>
    <title type="short" as="reported to house">Ensuring Compliance Against Drug Diversion Act of 2019</title>
    <title type="short" as="introduced">Ensuring Compliance Against Drug Diversion Act of 2019</title>
    <title type="short" as="passed house">Ensuring Compliance Against Drug Diversion Act of 2020</title>
    <title type="short" as="passed house">Ensuring Compliance Against Drug Diversion Act of 2020</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to provide for the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances or list I chemicals, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="G000568"/>
  <cosponsors>
    <cosponsor bioguide_id="W000791" joined="2019-10-28"/>
  </cosponsors>
  <actions>
    <action datetime="2019-10-23">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-10-23" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-10-23">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-10-26">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-11-15">
      <text>Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.</text>
    </action>
    <action datetime="2020-09-09">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2020-09-09" state="REPORTED">
      <text>Ordered to be Reported by Voice Vote.</text>
    </action>
    <action datetime="2020-11-16">
      <text>Reported by the Committee on Energy and Commerce. H. Rept. 116-584, Part I.</text>
    </action>
    <action datetime="2020-11-16">
      <text>Committee on the Judiciary discharged.</text>
    </action>
    <calendar datetime="2020-11-16" calendar="Union" number="482">
      <text>Placed on the Union Calendar, Calendar No. 482.</text>
    </calendar>
    <action datetime="2020-11-17T13:36:00-05:00">
      <text>Mr. Pallone moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2020-11-17T13:36:19-05:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H5819-5820" label="consideration"/>
    </action>
    <action datetime="2020-11-17T13:36:28-05:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4812.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2020-11-17T13:43:08-05:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H5819" label="text"/>
    </vote>
    <action datetime="2020-11-17T13:43:11-05:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2020-11-18">
      <text>Received in the Senate and Read twice and referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Discharged, Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Licensing and registrations"/>
  </subjects>
  <amendments/>
  <summary date="2021-02-11T20:56:34Z" status="Passed House">Ensuring Compliance Against Drug Diversion Act of 2020

This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances.

 It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.</summary>
  <committee-reports>
    <report>H. Rept. 116-584</report>
  </committee-reports>
</bill>
